Targeting PTEN using small molecule inhibitors.

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• PTEN (phosphatase and tensin homologue deleted on chromosome 10) functions as a tumor suppressor.
• PTEN counteracts phosphoinositide 3-kinase (PI3K) signaling through its lipid phosphatase activity.
• PTEN regulates Akt kinase, impacting insulin signaling, glucose uptake, and cell growth.

Purpose of the Study:

• To review the development and application of small molecules as PTEN inhibitors.
• To discuss current methodologies for assessing PTEN inhibition in vitro and in cellulo.

Main Methods:

• Literature review of small molecule PTEN inhibitors.
• Discussion of in vitro and in cellulo assays for PTEN inhibition.

Main Results:

• Small molecules are being developed to target PTEN.
• Various methods exist to evaluate PTEN inhibition efficacy.

Conclusions:

• PTEN is a significant drug target for metabolic and cardiovascular diseases.
• Small molecule inhibitors offer a potential therapeutic avenue for conditions involving PTEN dysregulation.